IP Library Granted Patent US 10,350,241
Granted Patent B2
US 10,350,241 · App. 15/968,866 · Granted Jul 16, 2019

Trace elements

Inventor: William Alfred Smith (Dublin, IE)
Assignee: Warburton Technology Limited
A61K33/34A23K20/30A23K50/10A61K33/04A61K33/18A61K33/24A61K33/30A61K33/32A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,350,241
App. No.
15/968,866
Granted
Jul 16, 2019
Kind
B2
Abstract

A trace element solution comprises at least the following metals: zinc; manganese; selenium; and copper; and which comprises a concentration of the metals of at least 90 mg/ml. The solution may comprise the following concentrations: at least 60 mg/ml zinc; at least 10 mg/ml manganese; at least 5 mg/ml selenium; and at least 15 mg/ml copper. The solution may comprise chromium, iodine and chromium.

Claims (11)

1. A trace element aqueous injectable solution for veterinary use, comprising zinc, manganese, selenium, and copper, wherein the concentration of zinc ranges from 60 mg/ml up to a concentration that, in combination with said manganese, selenium, and copper, preserves the suitability for injection of the trace element aqueous injectable solution.

2. A trace element aqueous injectable solution for veterinary use according to claim 1 , further comprising chromium, wherein the concentration of zinc ranges from 60 mg/ml up to a concentration that, in combination with manganese, selenium, copper, and chromium, preserves the suitability for injection of the trace element aqueous injectable solution.

3. A trace element aqueous injectable solution for veterinary use according to claim 1 , wherein the concentration of manganese ranges from 10 mg/ml up to a concentration that, in combination with the concentration of the other metals, preserves the suitability of injection of the trace element aqueous injectable solution; the concentration of selenium ranges from 5 mg/ml up to a concentration of selenium that, in combination with the concentration of the other metals, preserves the suitability of injection of the trace element aqueous injectable solution; and the concentration of copper ranges from 15 mg/ml up to a concentration of copper that, in combination with the concentration of the other metals, preserves the suitability of injection of the trace element aqueous injectable solution.

4. A trace element aqueous injectable solution for veterinary use according to claim 3 , further comprising chromium, wherein the concentration of chromium ranges from 5 mg/ml up to a concentration of chromium that, in combination with the concentration of the other metals, preserves the suitability for injection of the trace element aqueous injectable solution.

5. A trace element aqueous injectable solution for veterinary use according to claim 4 , further comprising iodine, wherein the concentration of iodine in combination with the concentration of the metals preserves the suitability for injection of the trace element aqueous injectable solution.

6. A trace element aqueous injectable solution for veterinary use according to claim 5 , wherein the concentration of iodine ranges from 50 mg/ml up to 300 mg/ml and wherein the concentration of iodine in combination with the concentration of the metals preserves the suitability for injection of the trace element aqueous injectable solution.

7. A method of providing a trace element aqueous injectable solution of claim 1 to a livestock animal comprising injecting the trace element aqueous injectable solution of claim 1 into the livestock animal.

8. A trace element aqueous injectable solution for veterinary use, comprising zinc, manganese, selenium, and copper, wherein the concentration of zinc is 60 mg/ml, the concentration of manganese is 10 mg/ml, the concentration of selenium is 5 mg/ml, and the concentration of copper is 15 mg/ml.

9. A trace element aqueous injectable solution for veterinary use of claim 8 , further comprising chromium, wherein the concentration of chromium is 5 mg/l.

10. A trace element aqueous injectable solution for veterinary use of claim 9 , further comprising iodine, wherein the concentration of iodine ranges from 50 mg/ml up to 300 mg/mi.

11. A method of providing a trace element aqueous injectable solution of claim 8 to a livestock animal comprising injecting the trace element aqueous injectable solution of claim 8 into the livestock animal.

Assignments (5)
SECURITY INTEREST Recorded Jun 3, 2026
From: WARBURTON TECHNOLOGY LIMITED
To: ALTER DOMUS (US), LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 074840/0269 →
RELEASE OF SECURITY INTEREST Recorded Feb 13, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS ADMINISTRATIVE AGENT
To: AXIOTA U.S., INC. (F/K/A MS BIOTECH, INC.); WARBURTON TECHNOLOGY LIMITED
Reel/Frame 073791/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2024
From: SMITH, WILLIAM ALFRED
To: WARBURTON TECHNOLOGY LIMITED
Reel/Frame 067953/0444 →
ASSIGNMENT AND ASSUMPTION AGREEMENT Recorded Mar 17, 2023
From: U.S. BANK NATIONAL ASSOCIATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 063115/0486 →
SECURITY INTEREST Recorded Dec 24, 2019
From: WARBURTON TECHNOLOGY LIMITED
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051363/0001 →
Priority Claims (1)
ZA 200810426 · Dec 9, 2008 · national
Continuity (3)
Continuation 15660439 · Jul 26, 2017
Division 13130336
Related Publication 20180250334A1 · Sep 6, 2018